Delivery Order SPE2DB22D3501-SPE2DB24FWA19
Award Date
6/18/24
Potential Completion Date
6/20/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566734673 OXCARBAZEPINE ER 600 MG TABLET 100S. The contract has a ceiling value of $5,945.20 and an ultimate completion date of December 17, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,481.62 firm fixed-price delivery order is for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary...
This federal contract award, identified as SPE2DB22D2007|SPE2DB24FJ2KG, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4564558250 - OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, a pharmaceutical product, with a ceiling value of $4,221.31 and an ultimate completion date of May 10, 2024. The contract is a Delivery Order and is priced as a Firm Fixed Price. It is not designated as a set-aside contract....
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUJK4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,482.78 firm fixed-price delivery order is for the supply of 4566420572 - OXCARBAZEPINE 300 MG TABLET 100S. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,629.05 firm fixed-price delivery order is for the supply of 100 units of the medication OXCARBAZEPINE ER 600 MG TABLET. The contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,966.93, is for the delivery of 4563374242 - Oxcarbazepine 300 mg/5 ml Suspension 250 ml. The contract is a Delivery Order with a Firm Fixed Price type and has an ultimate completion date of January 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4564340550 - OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, with a ceiling value of $1,673.72 and a performance period ending on April 22, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract, valued at $3,268.33, is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of October 30, 2023 and was awarded on October 27, 2022. This contract is not...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The $4,104.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $3,843.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OXCARBAZEPINE ER 150 MG TABLET 100S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 1, 2024. It is not designated as a...